AU Patent

AU2010231494A1 — Genetic markers for risk management of atrial fibrillation and stroke

Assigned to Decode Genetics ehf · Expires 2011-11-03 · 15y expired

What this patent protects

116The invention relates to procedures and methods of determining a susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter and Stroke, by assessing the presence or absence of alleles at polymorphic markers found to be associated with risk of these con…

USPTO Abstract

116The invention relates to procedures and methods of determining a susceptibility to cardiac arrhythmia, including Atrial Fibrillation, Atrial Flutter and Stroke, by assessing the presence or absence of alleles at polymorphic markers found to be associated with risk of these conditions. The invention further relates to kits encompassing reagents for assessing such markers, and diagnostic 5 methods, uses and procedures for utilizing such susceptibility markers.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010231494A1
Jurisdiction
AU
Classification
—
Expires
2011-11-03
Drug substance claim
No
Drug product claim
No
Assignee
Decode Genetics ehf
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.